HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
(Bloomberg) Kallyope Inc., a US biotech that’s developing oral weight loss drugs, is exploring an initial public offering, according to people familiar with the matter, as the company seeks to capitalize on the investor frenzy around treatments for obesity. Most Read from BloombergChina Weighs Stock Market Rescue Package Backed by $278 BillionApple Dials Back Car’s Self-Driving Features and Delays Launch to 2028Netflix Pays $5 Billion for ‘Raw’ in Bet on Live EventsAn Isolated Israel Doubles
As COVID-19 cases rise in New Mexico, health officials returned after two months to discuss the pandemic, which they say continues, but is not causing the same severe outcomes
Toronto, ON (PRWEB) March 16, 2022 Poorly water-soluble active pharmaceutical ingredients (APIs) pose one of the most common challenges in drug product